Lexicon Pharmaceuticals
LXRX
#6808
Rank
$0.63 B
Marketcap
$1.52
Share price
15.15%
Change (1 day)
105.41%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) Fails to deliver data

Key failure to deliver metrics for Lexicon Pharmaceuticals :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Lexicon Pharmaceuticals (LXRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Lexicon Pharmaceuticals (LXRX) - since 2015

Volume in USD (price x number of shares), data since 2015

Lexicon Pharmaceuticals (LXRX) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026$0.08 M-99.34%
2025$12.43 M-38.43%
2024$20.19 M111.04%
2023$9.57 M315.88%
2022$2.3 M-91.22%
2021$26.2 M1.63%
2020$25.78 M21.18%
2019$21.27 M-6.95%
2018$22.86 M-27.5%
2017$31.53 M18.35%
2016$26.64 M59.83%
2015$16.67 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Thermo Fisher Scientific
TMO
$6.31 M$69.73 M๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
$8.54 M$22.72 M๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
$2.75 M$61.72 M๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
$3.65 M$9.37 M๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$4.14 M$11.43 M๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
$3.5 M$7.97 M๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
N/A$0.94 M๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$8.07 M$14.34 M๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
N/A$0.09 M๐Ÿ‡บ๐Ÿ‡ธ USA